Location: San Francisco, CA
CIK: 0001799883 · Show all filings
Period: Q3 2023 (← Previous) (Next →)
Filing Date: Nov 14, 2023
Total Value: $348M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ELVN | ENLIVEN THERAPEUTICS INC | 5,160,975 | $70.5M | 20.3% | $20.34 | -17.2% | COM | 29337E102 |
| TRDA | ENTRADA THERAPEUTICS INC | 4,408,379 | $69.65M | 20.0% | $17.12 | — | COM | 29384C108 |
| IRON | DISC MEDICINE INC | 438,442 | $20.6M | 5.9% | $49.79 | +0.5% | COM | 254604101 |
| DNTH | DIANTHUS THERAPEUTICS INC | 1,472,264 | $20.13M | 5.8% | $12.62 | 0.0% | COM | 252828108 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 313,210 | $17.85M | 5.1% | $25.81 | +113.9% | CLASS A ORD | 61559X104 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 462,286 | $13.75M | 4.0% | $19.04 | +8.2% | COM | 22663K107 |
| — | VOR BIOPHARMA INC | 6,361,723 | $13.49M | 3.9% | $43.10 | — | COM | 929033108 |
| PHVS | PHARVARIS N V | 587,600 | $12.26M | 3.5% | $18.63 | -1.0% | COM | N69605108 |
| — | RALLYBIO CORP | 3,630,724 | $12.24M | 3.5% | $17.58 | — | COM | 75120L100 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 490,000 | $9.829M | 2.8% | $23.99 | +5.8% | COM | 98943L107 |
| — | SCPHARMACEUTICALS INC | 1,200,647 | $8.549M | 2.5% | $5.92 | — | COM | 810648105 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 310,270 | $8.539M | 2.5% | $33.70 | -7.0% | COM NEW | 15117B202 |
| — | MIRATI THERAPEUTICS INC | 192,500 | $8.385M | 2.4% | $36.13 | — | COM | 60468T105 |
| COGT | COGENT BIOSCIENCES INC | 790,440 | $7.707M | 2.2% | $6.91 | +71.6% | COM | 19240Q201 |
| VKTX | VIKING THERAPEUTICS INC | 585,000 | $6.476M | 1.9% | $14.60 | -2.0% | COM | 92686J106 |
| ANAB | ANAPTYSBIO INC | 357,733 | $6.425M | 1.8% | $28.24 | -32.4% | COM | 032724106 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 410,000 | $6.289M | 1.8% | $18.33 | +4.1% | COM | 92790C104 |
| ARVN | ARVINAS INC | 320,000 | $6.285M | 1.8% | $29.28 | -16.2% | COM | 04335A105 |
| TYRA | TYRA BIOSCIENCES INC | 411,450 | $5.666M | 1.6% | $14.83 | 0.0% | COM | 90240B106 |
| — | SPRUCE BIOSCIENCES INC | 2,364,000 | $5.343M | 1.5% | $2.21 | — | COM | 85209E109 |
| — | HOMOLOGY MEDICINES INC | 4,535,919 | $5.307M | 1.5% | $20.70 | — | COM | 438083107 |
| RNAM | AVIDITY BIOSCIENCES INC | 665,555 | $4.246M | 1.2% | $18.92 | -54.5% | COM | 05370A108 |
| GHRS | GH RESEARCH PLC | 404,404 | $4.064M | 1.2% | $11.07 | +4.4% | ORDINARY SHARES | G3855L106 |
| — | MERSANA THERAPEUTICS INC | 1,305,000 | $1.657M | 0.5% | $4.03 | — | COM | 59045L106 |
| — | IMPEL PHARMACEUTICALS INC | 2,884,791 | $1.24M | 0.4% | $8.85 | — | COM | 45258K109 |
| — | CIDARA THERAPEUTICS INC | 1,134,511 | $1.069M | 0.3% | $3.84 | — | COM | 171757107 |